HealthRX vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hers beats HealthRX overall, scoring 7.3/10 vs 5.2/10. HealthRX is more affordable at $99/mo vs $199/mo. Choose HealthRX for cash-pay patients who want low flat-dose compounded glp-1 pr. Choose Hers for women who want brand-name wegovy (injection or pill) at $149.
A side-by-side look at HealthRX and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
HealthRX
#50 of 53HealthRX is a cash-pay telehealth platform for compounded injectable semaglutide and tirzepatide. Its July 2026 landing page lists semaglutide at $133/mo on a 3-month plan or $99/mo on a 12-month plan, plus tirzepatide at $209/mo or $179/mo. Prices stay flat across doses and include clinician review, dose adjustments, and overnight shipping. MD Integrations supplies the clinician network, while the dispensing 503A pharmacy remains unnamed on the public site.
Visit HealthRXHers
#34 of 53The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit Hers| Feature | HealthRX | Hers |
|---|---|---|
| Our Score | 5.2/10 | 7.3/10 |
| Starting Price | $99/mo | $199/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want low flat-dose compounded GLP-1 pricing, all-50-state access, fast shipping, and self-service cancellation | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand |
| Ranking | #50 | #34 |
| Get started | Visit HealthRX | Visit Hers |
Pros & Cons Compared
HealthRX
Pros
- +$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
- +Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
- +Licensed clinicians in all 50 states through MD Integrations, with most files reviewed within about 24 hours
- +LegitScript certificate 50087439 links to the issuer's verification checker
- +Single-click account cancellation and refunds for unshipped doses
- +Published HIPAA notice, telehealth consent, safety information, and emergency instructions
Cons
- −The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
- −Legal entity, headquarters, executive team, and medical director remain undisclosed
- −The tirzepatide product page advertises $149/mo while the current affiliate landing and FAQ say $179/mo, so confirm the checkout rate
- −The 4.8/5 from 12,000+ members block uses illustrative composites rather than an independent review platform
- −Cash-pay only, with no insurance billing or prior-authorization support
- −Compounded medications sit outside FDA premarket approval as finished products
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Our Verdict
Hers edges out HealthRX with a score of 7.3/10 vs 5.2/10. If budget is your priority, HealthRX starts at $99/mo compared to Hers's $199/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose HealthRX if you want: cash-pay patients who want low flat-dose compounded glp-1 pricing, all-50-state access, fast shipping, and self-service cancellation. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither HealthRX nor Hers feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing HealthRX or Hers tend to look at next.
- HealthRX vs Yucca Health$146/mo
- HealthRX vs Wellorithm$147/mo
- HealthRX vs Novi$133/mo
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.